Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Investigative Dermatology|March 5, 2002
Nerve growth factor, neuropeptides, and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in miceScott L Townley, Michele A Grimbaldeston, Ian Ferguson, et al.British Journal of Cancer|July 13, 2013
Circulating microRNAs predict biochemical recurrence in prostate cancer patientsL A Selth, S L Townley, A G Bert, et al.Nature Communications|April 21, 2011
Respiratory distress and perinatal lethality in Nedd4-2-deficient miceNatasha A Boase, Grigori Y Rychkov, Scott L Townley, et al.Cancer Research|May 6, 2017
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate CancerSteve Paltoglou, Rajdeep Das, Scott L Townley, et al.Science Translational Medicine|September 4, 2020
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Camille Devereux, et al.Nature Communications|June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancerZifeng Wang, Scott L Townley, Songqi Zhang, et al.Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.Cancer Research|April 24, 2024
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain FerroptosisRaj K Shrestha, Zeyad D Nassar, Adrienne R Hanson, et al.Cell Death & Disease|June 2, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancerDanielle Meiwen Fang, Raj K Shrestha, Beatriz German, et al.British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.Pageof 3